Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Bone development and remodeling in metabolic disorders.

Serra-Vinardell J, Roca-Ayats N, De-Ugarte L, Vilageliu L, Balcells S, Grinberg D.

J Inherit Metab Dis. 2019 Apr 3. doi: 10.1002/jimd.12097. [Epub ahead of print]

PMID:
30942483
2.

Glucocerebrosidase haploinsufficiency in A53T α-synuclein mice impacts disease onset and course.

Tayebi N, Parisiadou L, Berhe B, Gonzalez AN, Serra-Vinardell J, Tamargo RJ, Maniwang E, Sorrentino Z, Fujiwara H, Grey RJ, Hassan S, Blech-Hermoni YN, Chen C, McGlinchey R, Makariou-Pikis C, Brooks M, Ginns EI, Ory DS, Giasson BI, Sidransky E.

Mol Genet Metab. 2017 Dec;122(4):198-208. doi: 10.1016/j.ymgme.2017.11.001. Epub 2017 Nov 21.

3.

Expression profiling of microRNAs in human bone tissue from postmenopausal women.

De-Ugarte L, Serra-Vinardell J, Nonell L, Balcells S, Arnal M, Nogues X, Mellibovsky L, Grinberg D, Diez-Perez A, Garcia-Giralt N.

Hum Cell. 2018 Jan;31(1):33-41. doi: 10.1007/s13577-017-0181-y. Epub 2017 Sep 20.

PMID:
28933035
4.

Correction: Stereodivergent synthesis of right- and left-handed iminoxylitol heterodimers and monomers. Study of their impact on β-glucocerebrosidase activity.

Stauffert F, Serra-Vinardell J, Gómez-Grau M, Michelakakis H, Mavridou I, Grinberg D, Vilageliu L, Casas J, Bodlenner A, Delgado A, Compain P.

Org Biomol Chem. 2017 Sep 26;15(37):7977. doi: 10.1039/c7ob90148h.

PMID:
28905961
5.

Induced pluripotent stem cell models of lysosomal storage disorders.

Borger DK, McMahon B, Roshan Lal T, Serra-Vinardell J, Aflaki E, Sidransky E.

Dis Model Mech. 2017 Jun 1;10(6):691-704. doi: 10.1242/dmm.029009. Review.

6.

Stereodivergent synthesis of right- and left-handed iminoxylitol heterodimers and monomers. Study of their impact on β-glucocerebrosidase activity.

Stauffert F, Serra-Vinardell J, Gómez-Grau M, Michelakakis H, Mavridou I, Grinberg D, Vilageliu L, Casas J, Bodlenner A, Delgado A, Compain P.

Org Biomol Chem. 2017 May 3;15(17):3681-3705. doi: 10.1039/c7ob00443e. Erratum in: Org Biomol Chem. 2017 Sep 26;15(37):7977.

PMID:
28401966
7.

Investigation of original multivalent iminosugars as pharmacological chaperones for the treatment of Gaucher disease.

Laigre E, Hazelard D, Casas J, Serra-Vinardell J, Michelakakis H, Mavridou I, Aerts JM, Delgado A, Compain P.

Carbohydr Res. 2016 Jun 24;429:98-104. doi: 10.1016/j.carres.2016.03.007. Epub 2016 Mar 16.

PMID:
27063390
8.

Selective chaperone effect of aminocyclitol derivatives on G202R and other mutant glucocerebrosidases causing Gaucher disease.

Serra-Vinardell J, Díaz L, Gutiérrez-de Terán H, Sánchez-Ollé G, Bujons J, Michelakakis H, Mavridou I, Aerts JM, Delgado A, Grinberg D, Vilageliu L, Casas J.

Int J Biochem Cell Biol. 2014 Sep;54:245-54. doi: 10.1016/j.biocel.2014.07.017. Epub 2014 Jul 30.

PMID:
25084554
9.

Glucocerebrosidase enhancers for selected Gaucher disease genotypes by modification of α-1-C-substituted imino-D-xylitols (DIXs) by click chemistry.

Serra-Vinardell J, Díaz L, Casas J, Grinberg D, Vilageliu L, Michelakakis H, Mavridou I, Aerts JM, Decroocq C, Compain P, Delgado A.

ChemMedChem. 2014 Aug;9(8):1744-54. doi: 10.1002/cmdc.201402023. Epub 2014 Jun 27.

PMID:
24976039

Supplemental Content

Loading ...
Support Center